EUVIMEDEUVIMED entdecken
Crossref

Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence

Yijie Li, Ranyun Chen, Jianzhi Wu, Xiaoyong Xue, Tiegang Liu, Guiying Peng, Ruiyu Wu, Lei Wang, Kexin Jia, Yajie Cai, Xiaojiaoyang Li iD

Phytotherapy Research · 2024

DOI: 10.1002/ptr.8070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Yijie Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China. Hauptthemen laut MEDLINE: Lung, Idiopathic Pulmonary Fibrosis, Benzofurans, Depsides. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF), as the most common idiopathic interstitial pneumonia, is caused by a complex interaction of pathological mechanisms. Interestingly, IPF frequently occurs in the middle‐aged and elderly populations but rarely affects young people. Salvianolic acid B (SAB) exerts antioxidant, antiinflammatory, and antifibrotic bioactivities and is considered a promising drug for pulmonary disease treatment. However, the pharmacological effects and mechanisms of SAB on cellular senescence of lung cells and IPF development remain unclear. We used bleomycin (BLM)‐induced pulmonary fibrosis mice and different lung cells to investigate the antisenescence impact of SAB and explain its underlying mechanism by network pharmacology and the Human Protein Atlas database. Here, we found that SAB significantly prevented pulmonary fibrosis and cellular senescence in mice, and reversed the senescence trend and typical senescence‐associated secretory phenotype (SASP) factors released from lung macrophages and alveolar type II (AT2) epithelial cells, which further reduced lung fibroblasts activation. Additionally, SAB alleviated the epithelial–mesenchymal transition process of AT2 cells induced by transforming growth factor beta. By predicting potential targets of SAB that were then confirmed by chromatin immunoprecipitation‐qPCR technology, we determined that SAB directly hampered the binding of transcription factor stimulating protein 1 to the promoters of SASPs (P21 and P16), thus halting lung cell senescence. We demonstrated that SAB reduced BLM‐induced AT2 and macrophage senescence, and the subsequent release of SASP factors that activated lung fibroblasts, thereby dual‐relieving IPF. This study provides a new scientific foundation and perspective for pulmonary fibrosis therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LungIdiopathic Pulmonary FibrosisBenzofuransDepsidesMiddle AgedAgedHumansMiceAnimalsAdolescentCellular SenescenceMacrophages, AlveolarBleomycin

Stichwörter der Autor:innen

SP1cell senescenceidiopathic pulmonary fibrosissalvianolic acid Bsenescence-associated secretory phenotype

Substanzen

salvianolic acid BBleomycinBenzofuransDepsides

Autor:innen und Institutionen

  • School of Life Sciences, Beijing University of Chinese Medicine, Beijing, China.
  • School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.
  • School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.

ORCID-Profile: Xiaojiaoyang Li

Förderung

  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • National High-Level Talents Special Support Program
  • National Key Research and Development Program on Modernization of Traditional Chinese Medicine

Zitieren

APA

Li, Y., Chen, R., Wu, J., Xue, X., Liu, T., Peng, G., Wu, R., Wang, L., Jia, K., Cai, Y., & Li, X. (2024). Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence. Phytotherapy Research. https://doi.org/10.1002/ptr.8070

Vancouver

Li Y, Chen R, Wu J, Xue X, Liu T, Peng G, et al. Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence. Phytotherapy Research. 2024. doi:10.1002/ptr.8070

BibTeX
@article{Li2024,
  author = {Li, Yijie and Chen, Ranyun and Wu, Jianzhi and Xue, Xiaoyong and Liu, Tiegang and Peng, Guiying and Wu, Ruiyu and Wang, Lei and Jia, Kexin and Cai, Yajie and Li, Xiaojiaoyang},
  title = {Salvianolic acid B protects against pulmonary fibrosis by attenuating stimulating protein 1‐mediated macrophage and alveolar type 2 cell senescence},
  journal = {Phytotherapy Research},
  year = {2024},
  doi = {10.1002/ptr.8070}
}
Kostenlos starten →